Interaction of spironolactone and digitalis with the 5α dihydrotestosterone (DHT) receptor of rat ventral prostate

J. C. Pita, M. E. Lippman, E. B. Thompson, Donald (Lynn) Loriaux

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

The aldosterone antagonist, spironolactone, has been shown to block the effects of exogenously administered androgen in rat. This suggests that interaction of the drug with androgen at the target tissues may occur. In this paper we have studied the possible interaction of spironolactone with the 5α dihydrotestosterone (DHT)1 receptor of rat ventral prostate. The competitive receptor assay used involves precipitation of the 105,000 x g supernatant of the homogenized tissue with protamine sulfate, removal of the unprecipitated cytosol, and incubation of the precipitate in the presence of the appropriate [3H]DHT steroid solution at O C for 18 hours. Using this method the Kd (dissociation constant) for DHT in the rat prostate was in the range of 1.9 4.0 x 10-9M and the binding capacity was 0.21 pmol/mg protein. Spironolactone was found to interfere with the binding of DHT to the precipitated cytosol and displayed an estimated Kd of 1.3 4.6 x 10-8M. Several digitalis preparations were similarly studied. Digitoxin and digitoxigenin also interfered with the binding of [3H]DHT and had an estimated Kd of 0.8 3.6 x 10-8M. Digoxin interacted less strongly and its estimated Kd was 10-6M. We believe these results suggest an interaction of spironolactone and digitalis with the DHT receptor and may help explain some of their antiandrogenic actions in the rat and in man.

Original languageEnglish (US)
Pages (from-to)1521-1527
Number of pages7
JournalEndocrinology
Volume97
Issue number6
StatePublished - 1975
Externally publishedYes

Fingerprint

Spironolactone
Digitalis
Dihydrotestosterone
Androgen Receptors
Prostate
Cytosol
Androgens
Digitoxigenin
Digitoxin
Mineralocorticoid Receptor Antagonists
Protamines
Digoxin
Drug Interactions
Steroids
Proteins

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Interaction of spironolactone and digitalis with the 5α dihydrotestosterone (DHT) receptor of rat ventral prostate. / Pita, J. C.; Lippman, M. E.; Thompson, E. B.; Loriaux, Donald (Lynn).

In: Endocrinology, Vol. 97, No. 6, 1975, p. 1521-1527.

Research output: Contribution to journalArticle

@article{ba3c689338ac4e138432d92dc67d919d,
title = "Interaction of spironolactone and digitalis with the 5α dihydrotestosterone (DHT) receptor of rat ventral prostate",
abstract = "The aldosterone antagonist, spironolactone, has been shown to block the effects of exogenously administered androgen in rat. This suggests that interaction of the drug with androgen at the target tissues may occur. In this paper we have studied the possible interaction of spironolactone with the 5α dihydrotestosterone (DHT)1 receptor of rat ventral prostate. The competitive receptor assay used involves precipitation of the 105,000 x g supernatant of the homogenized tissue with protamine sulfate, removal of the unprecipitated cytosol, and incubation of the precipitate in the presence of the appropriate [3H]DHT steroid solution at O C for 18 hours. Using this method the Kd (dissociation constant) for DHT in the rat prostate was in the range of 1.9 4.0 x 10-9M and the binding capacity was 0.21 pmol/mg protein. Spironolactone was found to interfere with the binding of DHT to the precipitated cytosol and displayed an estimated Kd of 1.3 4.6 x 10-8M. Several digitalis preparations were similarly studied. Digitoxin and digitoxigenin also interfered with the binding of [3H]DHT and had an estimated Kd of 0.8 3.6 x 10-8M. Digoxin interacted less strongly and its estimated Kd was 10-6M. We believe these results suggest an interaction of spironolactone and digitalis with the DHT receptor and may help explain some of their antiandrogenic actions in the rat and in man.",
author = "Pita, {J. C.} and Lippman, {M. E.} and Thompson, {E. B.} and Loriaux, {Donald (Lynn)}",
year = "1975",
language = "English (US)",
volume = "97",
pages = "1521--1527",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Interaction of spironolactone and digitalis with the 5α dihydrotestosterone (DHT) receptor of rat ventral prostate

AU - Pita, J. C.

AU - Lippman, M. E.

AU - Thompson, E. B.

AU - Loriaux, Donald (Lynn)

PY - 1975

Y1 - 1975

N2 - The aldosterone antagonist, spironolactone, has been shown to block the effects of exogenously administered androgen in rat. This suggests that interaction of the drug with androgen at the target tissues may occur. In this paper we have studied the possible interaction of spironolactone with the 5α dihydrotestosterone (DHT)1 receptor of rat ventral prostate. The competitive receptor assay used involves precipitation of the 105,000 x g supernatant of the homogenized tissue with protamine sulfate, removal of the unprecipitated cytosol, and incubation of the precipitate in the presence of the appropriate [3H]DHT steroid solution at O C for 18 hours. Using this method the Kd (dissociation constant) for DHT in the rat prostate was in the range of 1.9 4.0 x 10-9M and the binding capacity was 0.21 pmol/mg protein. Spironolactone was found to interfere with the binding of DHT to the precipitated cytosol and displayed an estimated Kd of 1.3 4.6 x 10-8M. Several digitalis preparations were similarly studied. Digitoxin and digitoxigenin also interfered with the binding of [3H]DHT and had an estimated Kd of 0.8 3.6 x 10-8M. Digoxin interacted less strongly and its estimated Kd was 10-6M. We believe these results suggest an interaction of spironolactone and digitalis with the DHT receptor and may help explain some of their antiandrogenic actions in the rat and in man.

AB - The aldosterone antagonist, spironolactone, has been shown to block the effects of exogenously administered androgen in rat. This suggests that interaction of the drug with androgen at the target tissues may occur. In this paper we have studied the possible interaction of spironolactone with the 5α dihydrotestosterone (DHT)1 receptor of rat ventral prostate. The competitive receptor assay used involves precipitation of the 105,000 x g supernatant of the homogenized tissue with protamine sulfate, removal of the unprecipitated cytosol, and incubation of the precipitate in the presence of the appropriate [3H]DHT steroid solution at O C for 18 hours. Using this method the Kd (dissociation constant) for DHT in the rat prostate was in the range of 1.9 4.0 x 10-9M and the binding capacity was 0.21 pmol/mg protein. Spironolactone was found to interfere with the binding of DHT to the precipitated cytosol and displayed an estimated Kd of 1.3 4.6 x 10-8M. Several digitalis preparations were similarly studied. Digitoxin and digitoxigenin also interfered with the binding of [3H]DHT and had an estimated Kd of 0.8 3.6 x 10-8M. Digoxin interacted less strongly and its estimated Kd was 10-6M. We believe these results suggest an interaction of spironolactone and digitalis with the DHT receptor and may help explain some of their antiandrogenic actions in the rat and in man.

UR - http://www.scopus.com/inward/record.url?scp=0016693856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016693856&partnerID=8YFLogxK

M3 - Article

C2 - 173527

AN - SCOPUS:0016693856

VL - 97

SP - 1521

EP - 1527

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 6

ER -